Conto economico
ASTRANA HEALTH, INC.
ASTH
Riepilogo performance
Clicca su una riga della tabella per aggiungerla al grafico
in milioni di USD
| Voce | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Mar 31, 2017 2016 FY | Mar 31, 2016 2015 FY | Mar 31, 2015 2014 FY | Jan 31, 2014 2013 FY | Jan 31, 2013 2012 FY | Jan 31, 2012 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ricavi
|
3,181.77 | 2,034.54 | 1,386.66 | 1,144.16 | 773.92 | 687.18 | 560.62 | 519.91 | 357.75 | 57.43 | 44.05 | 32.99 | 10.48 | 7.78 | 5.11 |
|
Costo del venduto
|
- | - | - | - | 596.14 | 539.21 | 467.80 | 361.13 | - | - | - | - | - | - | - |
|
Utile lordo
|
3,181.77 | 2,034.54 | 1,386.66 | 1,144.16 | 177.77 | 147.97 | 92.81 | 158.78 | 357.75 | 57.43 | 44.05 | 32.99 | 1.41 | 1.46 | 0.98 |
|
Spese operative
|
217.66 | 154.11 | 112.60 | 77.67 | 62.08 | 49.12 | 528.20 | 431.48 | 322.60 | 67.96 | 51.31 | 33.68 | 5.32 | 3.54 | 1.39 |
|
Ricerca e sviluppo
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Spese commerciali, generali e amministrative
|
217.66 | 154.11 | 112.60 | 77.67 | 62.08 | 49.12 | 41.48 | 43.35 | 26.44 | 18.58 | 16.96 | 11.28 | 5.29 | 3.52 | 1.38 |
|
Altre spese operative
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Reddito operativo
|
2,964.11 | 1,880.43 | 1,274.06 | 1,066.49 | 115.70 | 98.85 | -435.38 | -272.70 | 35.15 | -10.54 | -7.27 | -0.69 | -3.91 | -2.08 | -0.41 |
|
Proventi/oneri non operativi
|
-38.92 | -8.53 | 5.23 | -17.65 | -20.43 | 97.92 | -6.58 | -5.81 | 14.57 | 1.81 | -0.98 | -0.49 | -0.63 | -6.82 | -0.30 |
|
Proventi da interessi
|
12.16 | 14.51 | 14.21 | 1.98 | 1.57 | 2.81 | 2.02 | 1.26 | 1.02 | - | - | - | - | - | - |
|
Oneri finanziari
|
4.10 | 1.80 | 16.10 | 7.92 | 5.39 | 9.50 | 4.73 | 0.56 | 0.08 | 0.08 | 0.54 | 1.33 | 0.68 | 0.93 | 0.13 |
|
Altri proventi/oneri non operativi
|
1.71 | 4.45 | 5.58 | 5.62 | 0.52 | 3.69 | 0.30 | 6.00 | 0.95 | 0.01 | 0.24 | 0.00 | - | -0.04 | - |
|
Risultato prima delle imposte
|
39.61 | 80.82 | 89.84 | 86.62 | 77.75 | 178.43 | 25.84 | 82.63 | 49.71 | -8.73 | -8.24 | -1.18 | -4.54 | -8.90 | -0.71 |
|
Imposte sul reddito
|
12.51 | 37.67 | 29.12 | 37.57 | 3.89 | 140.56 | 11.72 | 71.79 | 23.91 | 0.24 | 1.10 | 0.62 | -4.54 | 0.00 | 0.01 |
|
Utile di pertinenza di terzi
|
1.59 | 6.78 | -2.87 | 1.48 | -24.56 | 84.45 | 3.56 | 49.43 | 20.02 | 0.29 | 1.17 | 0.45 | - | - | - |
|
Utile netto
|
27.10 | 43.15 | 60.72 | 49.05 | 73.86 | 37.87 | 14.12 | 10.84 | 25.80 | -8.97 | -9.34 | -1.80 | 0.00 | -8.90 | -0.72 |
Informazioni supplementari
Dati per azione, voci derivate e altre – non facenti parte del conto economico
in milioni di USD, salvo diversa indicazione
| Voce | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Mar 31, 2017 2016 FY | Mar 31, 2016 2015 FY | Mar 31, 2015 2014 FY | Jan 31, 2014 2013 FY | Jan 31, 2013 2012 FY | Jan 31, 2012 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ammortamenti e svalutazioni
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
3,009.86 | 1,908.36 | 1,291.81 | 1,084.04 | 133.21 | 117.20 | -416.63 | -253.40 | 54.22 | -9.89 | -6.91 | -0.36 | -3.88 | -2.06 | -0.41 |
|
Utile per azione (base)
|
0.46 | 0.91 | 1.30 | 1.09 | 1.69 | 1.04 | 0.41 | 0.33 | 1.01 | - | - | - | - | - | - |
|
Utile per azione diluito
|
0.46 | 0.90 | 1.29 | 1.08 | 1.63 | 1.01 | 0.39 | 0.29 | 0.90 | - | - | - | - | - | - |
|
Media ponderata azioni
|
49.08 | 47.60 | 46.55 | 44.97 | 43.83 | 36.53 | 34.71 | 32.89 | 25.53 | - | - | - | - | - | - |
|
Media ponderata diluita azioni
|
49.37 | 47.97 | 46.94 | 45.60 | 45.40 | 37.45 | 36.40 | 37.91 | 28.66 | - | - | - | - | - | - |
|
Conto economico complessivo
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |